EuroBiotech—More Articles of Note
> BioMed X and Boehringer Ingelheim added another strand to their multiyear collaboration. The new project will support research into targets for early interventions into psychiatric diseases. Release
> Nanobiotix unveiled plans to list its stock in the U.S. Statement
> Boehringer Ingelheim teamed up with Bioharmony Therapeutics to develop bacteriophage lysins to treat multidrug resistant infections. Release
> Sanofi secured access to Biomunex Pharmaceuticals' techn...